Long-term survival in a child with severe encephalopathy, multiple respiratory chain deficiency and GFM1 mutations
Sara Brito1, Kyle Thompson2, Jaume Campistol3
1Serviço de Pediatria, Centro Hospitalar de Leiria, Hospital de Santo André Leiria, Portugal ; Neuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu Barcelona, Spain.
Insights
Novel mutations in the GFM1 gene cause mitochondrial translation defects, leading to severe early-onset disease. This case highlights a GFM1 mutation patient with a stable course, surviving beyond childhood.
Area of Science:
- Genetics
- Molecular Biology
- Biochemistry
Background:
- Mitochondrial diseases often stem from OXPHOS system deficiencies.
- Nuclear gene defects impacting mitochondrial translation cause severe phenotypes.
Observation:
- An infant presented with severe encephalopathy, seizures, and lactic acidemia.
- Brain imaging showed corpus callosum thinning and white matter alterations.
- Genetic analysis revealed novel GFM1 mutations.
Findings:
- The GFM1 gene encodes mitochondrial translation elongation factor G1 (mtEFG1).
- Mutations resulted in combined OXPHOS deficiencies.
- This patient exhibited a stable clinical course, unlike previously reported fatal cases.
Implications:
- GFM1 gene defects increase susceptibility to neurological and hepatic dysfunction.
- This case expands the known GFM1-related disease spectrum and prognosis.
- Understanding these mutations is crucial for diagnosing and managing mitochondrial disorders.
Background:
Mitochondrial diseases due to deficiencies in the mitochondrial oxidative phosphorylation system (OXPHOS) can be associated with nuclear genes involved in mitochondrial translation, causing heterogeneous early onset and often fatal phenotypes.
Case Report:
The authors describe the clinical features and diagnostic workup of an infant who presented with an early onset severe encephalopathy, spastic-dystonic tetraparesis, failure to thrive, seizures and persistent lactic acidemia. Brain imaging revealed thinning of the corpus callosum and diffuse alteration of white matter signal. Genetic investigation confirmed two novel mutations in the GFM1 gene, encoding the mitochondrial translation elongation factor G1 (mtEFG1), resulting in combined deficiencies of OXPHOS.
Discussion:
The patient shares multiple clinical, laboratory and radiological similarities with the 11 reported patients with mutations involving this gene, but presents with a stable clinical course without metabolic decompensations, rather than a rapidly progressive fatal course. Defects in GFM1 gene confer high susceptibility to neurologic or hepatic dysfunction and this is, to the best of our knowledge, the first described patient who has survived beyond early childhood. Reporting of such cases is essential so as to delineate the key clinical and neuroradiological features of this disease and provide a more comprehensive view of its prognosis.
More Related Videos
10:16In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
08:56Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
Related Concept Videos
Acute Respiratory Failure-III
Inborn Errors of Metabolism
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Cystic Fibrosis: Management
Sinus disease and chronic...
